Requip PD 24 Hour Prolonged Release Tablets (4mg)
Product details
Registration number: SIN13764P
Classification: Prescription Only
Active ingredients: (Active Layer) ROPINIROLE HYDROCHLORIDE EQV ROPINIROLE
Strength: 4 mg
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: N04BC04
HSA approval date: 11 February 2010
Manufacturer(s): Glaxo Wellcome S.A.
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for Requip PD 24 Hour Prolonged Release Tablets (4mg)?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13764P
Classification: Prescription Only
What active ingredients and strength are recorded for Requip PD 24 Hour Prolonged Release Tablets (4mg)?
According to the HSA dataset updated 7 August 2026:
Active ingredients: (Active Layer) ROPINIROLE HYDROCHLORIDE EQV ROPINIROLE
Strength: 4 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Requip PD 24 Hour Prolonged Release Tablets (4mg)?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for Requip PD 24 Hour Prolonged Release Tablets (4mg)?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for Requip PD 24 Hour Prolonged Release Tablets (4mg)?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Glaxo Wellcome S.A.
Manufacturing country/countries: SPAIN
Where can I look up Requip PD 24 Hour Prolonged Release Tablets (4mg) in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13764P or the exact product name Requip PD 24 Hour Prolonged Release Tablets (4mg). The general register link does not preselect this product.
What are the source dates for this Requip PD 24 Hour Prolonged Release Tablets (4mg) record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Requip PD 24 Hour Prolonged Release Tablets (4mg) record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13764P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)